Informações:
Falhas:
ID
31601
Descrição
A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00808418
Link
https://clinicaltrials.gov/show/NCT00808418
Palavras-chave
Versões (1)
- 11/09/2018 11/09/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
11 de setembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Prostate Cancer NCT00808418
Eligibility Prostate Cancer NCT00808418
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer NCT00808418
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Secondary malignant neoplasm of prostate
Item
confirmed metastatic prostate cancer
boolean
C0347001 (UMLS CUI [1])
Prior Chemotherapy Quantity | Disease Progression
Item
no more than one prior chemotherapy on which the disease progressed
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2])
C1265611 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2])
ECOG performance status
Item
ecog performance status of less than or equal to 2
boolean
C1520224 (UMLS CUI [1])
Bone Marrow function | Renal function | Liver function
Item
adequate bone marrow, renal and hepatic functions as defined in the protocol
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Neuropathy CTCAE Grades
Item
neuropathy less than or equal to 2
boolean
C0442874 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,2])
Venous access patent | Investigational New Drug Infusion Frequent
Item
reliable venous access for frequent study drug infusions
boolean
C3164222 (UMLS CUI [1])
C0013230 (UMLS CUI [2,1])
C0392877 (UMLS CUI [2,2])
C0332183 (UMLS CUI [2,3])
C0013230 (UMLS CUI [2,1])
C0392877 (UMLS CUI [2,2])
C0332183 (UMLS CUI [2,3])
Cardiovascular Disease
Item
significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
known active brain metastases
boolean
C0220650 (UMLS CUI [1])
Therapeutic procedure Cancer Other
Item
subjects that have received treatment for other malignancies with in the past 5 years
boolean
C0087111 (UMLS CUI [1,1])
C1707251 (UMLS CUI [1,2])
C1707251 (UMLS CUI [1,2])
Condition Uncontrolled Clinical Significance
Item
other clinically significant uncontrolled conditions
boolean
C0348080 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])
C0205318 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])